Recent News

Connect with us

522 News Items found
In the Lab
Pictured: Breast tumor treated with paclitaxel
Research Suggests New Drugs Could Boost the Effectiveness of Chemotherapy

Recent findings by Memorial Sloan Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.
Profile
Pictured: Hans-Guido Wendel
Genetic Causes of Blood Cancers Explored

German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.
Research Suggests Potential Immune Therapy for Preventing Breast Cancer Metastasis

A new therapy tested in mouse models appears to harness neutrophils, a type of white blood cell, to effectively prevent the spread of breast cancer cells.
Media Advisory
Pictured: David Solit
Researchers Discover Why New Melanoma Drug Stops Working

Research led by investigators at Memorial Sloan Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug, vemurafenib.
Pictured: Semanti Mukherjee
Semanti Mukherjee Successfully Defends Thesis

Semanti Mukherjee successfully defended her thesis in September 2011. Her project focused on the genetic variants that contribute to the predisposition for and etiology of myeloproliferative neoplasms.
Pictured: Alison Spencer
Frontiers of Science Symposium

Gerstner Sloan Kettering sponsored a daylong symposium for undergraduates and their faculty advisors to meet Gerstner Sloan Kettering leaders and graduate students while enjoying faculty talks, student posters, and a visit to Memorial Sloan Kettering research facilities.
Pictured: Eric Alonzo
Eric Alonzo Successfully Defends Thesis

Eric Alonzo successfully defended his thesis in September 2011. He completed his dissertation research in the laboratory of Dr. Derek Sant'Angelo in the Immunology Program.
Pictured: Oakley Olsen & Johanna Joyce
Grayer Fellows Announced

Third-year students Oakley Olsen and Alison Spencer have been named Grayer Fellows. Fellows are chosen based on excellence demonstrated by their thesis proposal examinations.
Pictured: Douglas Levine
Genomic Analysis Provides Clues about Most Common Form of Ovarian Cancer

In a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan Kettering and other centers identified genetic mutations and pathways that set the disease apart from other types of ovarian cancer and other solid tumors.
MSK doctors
Memorial Sloan Kettering Researchers Discover How Gene Mutation Contributes to Leukemia

A study led by researchers at Memorial Sloan Kettering and New York University has shown that <i>TET2</i> loss enhances the function of blood stem cells, causing them to renew themselves more efficiently than normal blood stem cells.